Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
about
Functional contributions of carbohydrate on AIDS virus glycoproteinEnvelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challengeEvidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane proteinA novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysComparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.Models of RNA virus evolution and their roles in vaccine design.Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.Short communication: Simultaneous substitutions of V38M and N43T-N44K in the gp41 heptad repeat 1 (HR1) disrupt HIV type 1 gPr160 endoproteolytic cleavage (*).Glycosylation site-specific analysis of clade C HIV-1 envelope proteins.High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
P2860
Q30397572-4DDF206E-A37D-4F8B-94DE-57AB9BDBBA84Q34016211-0F06DBBE-22EA-4DED-A648-EEAB42C00F5CQ34120130-B9CD6304-2ECA-4D80-9F52-96FAB6F36C38Q34178259-7CDDBC05-E24C-4DB2-89E6-0DB7937207B5Q35665722-003122C1-C1D7-4C41-8DCD-402045BF0C90Q36363866-59D63DD5-7EA3-405E-B7C2-1E6E64CBF3BDQ36978861-E2317EC3-C670-4C1C-BA2F-5ECD8925E19EQ37808509-443D787C-8C71-43C7-B456-C2C11633BB63Q38659327-FE8CC7FE-C4E7-4AA5-BE78-0EB8AC9B7947Q39275435-A4F06C97-1199-4936-99BB-708841D6E580Q39754864-3D66A65E-39DB-4E43-BD55-69ADA0D364BCQ39824069-11C1A5A0-94E7-4063-8C13-F8A3F0058933Q47552258-D3D61F4B-4976-4981-8325-ECF64CB8A3C8
P2860
Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Glycosylation of gp41 of simia ...... s for neutralizing antibodies.
@en
type
label
Glycosylation of gp41 of simia ...... s for neutralizing antibodies.
@en
prefLabel
Glycosylation of gp41 of simia ...... s for neutralizing antibodies.
@en
P2093
P2860
P356
P1433
P1476
Glycosylation of gp41 of simia ...... s for neutralizing antibodies.
@en
P2093
Eloìsa Yuste
Jacqueline Bixby
Jeffrey Lifson
Ronald Desrosiers
Shuji Sato
Welkin Johnson
P2860
P304
12472-12486
P356
10.1128/JVI.01382-08
P407
P577
2008-10-01T00:00:00Z